Editorial Director, Addiction & Recovery · Last reviewed January 2025
Relapse — a return to substance use after a period of abstinence — is a common feature of substance use disorders, not a sign of treatment failure or moral weakness. The National Institute on Drug Abuse estimates that 40–60% of people in recovery from substance use disorders experience relapse at some point, a rate comparable to other chronic medical conditions like hypertension (50–70%) and asthma (50–70%).
Understanding relapse as a clinical event rather than a personal failure has important implications for treatment planning. It means that relapse prevention should be integrated into treatment from the beginning — and that relapse, when it occurs, should be addressed as a clinical matter requiring assessment and response, not as evidence that recovery is impossible.
The Relapse Process
Relapse is rarely a sudden event — it is typically a process that unfolds through stages. The model developed by psychologists G. Alan Marlatt and Judith Gordon, which forms the basis of most evidence-based relapse prevention approaches, describes relapse as a sequence of events that begins long before the first use of a substance.
Emotional Relapse
The first stage involves emotional and behavioral patterns that set the stage for eventual use — not thinking about using, but behaving in ways that increase vulnerability. Signs of emotional relapse include isolating from support, poor self-care (disrupted sleep, poor nutrition), not asking for help, and minimizing or denying problems. At this stage, the goal of relapse prevention is addressing these patterns before they progress.
Mental Relapse
Mental relapse involves an internal struggle — the beginning of thinking about using. This stage includes romanticizing past use, minimizing consequences, bargaining ("I'll just use once"), and planning opportunities to use. Cognitive-behavioral interventions are most effective at this stage.
Physical Relapse
Physical relapse involves the actual return to substance use. The first use — sometimes called a "lapse" — does not inevitably lead to a full return to prior use patterns. However, the abstinence violation effect — the shame, guilt, and catastrophic thinking that often follows a lapse — frequently accelerates the transition from a single lapse to a full relapse. Relapse prevention planning specifically addresses how to interrupt this cycle.
Triggers and High-Risk Situations
A core component of relapse prevention is identifying and developing coping strategies for triggers — internal and external cues that increase the likelihood of use. Common trigger categories include:
- Negative emotional states — Anxiety, depression, boredom, loneliness, and stress are among the most common relapse triggers, accounting for approximately 35% of relapses in Marlatt's research
- Interpersonal conflict — Arguments and relationship stressors
- Social pressure — Direct or indirect peer pressure to use
- Positive emotional states — Celebrations, events, and social situations associated with prior use
- Environmental cues — Locations, people, objects, or smells associated with use through classical conditioning
- Physical states — Pain, fatigue, illness, or the physiological symptoms of protracted withdrawal
Evidence-Based Relapse Prevention Strategies
Cognitive-Behavioral Relapse Prevention (CBRP)
Originally developed by Marlatt and Gordon, cognitive-behavioral relapse prevention is the most extensively validated relapse prevention approach. CBRP involves identifying high-risk situations and triggers, developing cognitive and behavioral coping skills, addressing the abstinence violation effect, and building lifestyle balance. Multiple meta-analyses have confirmed its efficacy for both alcohol and drug use disorders.
Mindfulness-Based Relapse Prevention (MBRP)
MBRP integrates mindfulness meditation practices with cognitive-behavioral relapse prevention. It teaches patients to observe cravings without reacting to them, to recognize high-risk situations with greater awareness, and to respond to emotional distress with equanimity rather than avoidance or impulsive action. A 2014 randomized controlled trial published in JAMA Psychiatry found MBRP superior to standard aftercare at 12-month follow-up for reducing substance use and heavy drinking.
Medication-Assisted Treatment as Relapse Prevention
For individuals with opioid or alcohol use disorder, MAT medications serve a relapse prevention function by reducing cravings and blocking the pleasurable effects of the substance. Extended-release naltrexone, in particular, is often framed explicitly as a relapse prevention intervention.
Continuing Care
Research consistently shows that longer engagement with treatment is associated with better long-term outcomes. Continuing care — transitioning to less intensive levels of treatment rather than ending treatment abruptly — is one of the most evidence-based things a person can do to reduce relapse risk. This includes stepping down from residential to IOP to outpatient, ongoing individual therapy, peer support participation, and regular check-ins with a prescribing physician if on MAT.
Responding to Relapse
If relapse occurs, the response matters enormously. Relapse should be treated as a clinical event requiring assessment — not as a reason to abandon treatment or conclude that recovery is impossible. The appropriate response depends on the severity of the return to use:
- A brief lapse may be addressable within the existing treatment context — by discussing it in therapy, identifying what led to it, and reinforcing coping strategies
- A more significant relapse may warrant a step-up in the level of care — returning to IOP from outpatient, or to residential from IOP
- A relapse involving overdose, injury, or severe disruption of functioning may require acute medical management followed by a reassessment of the treatment plan
What research does not support is treating relapse as the end of recovery or as evidence that a person is "not ready" for treatment. The evidence base is clear: most people who ultimately achieve sustained recovery have experienced relapse along the way.
Related: Levels of Care After Relapse · Sober Living as Relapse Prevention · Treating Co-Occurring Disorders